Technology Center Malta: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Technology Center Malta.

Press releases published on October 5, 2026

6 hours ago

DV Launches Attribution Measurement and Advances Brand Suitability for ChatGPT Ads

Indeterminate GlobeNewswire

6 hours ago

BioCryst Announces Formation of Scientific Advisory Board to Drive Rare Disease Pipeline Innovation and Growth

Indeterminate GlobeNewswire

6 hours ago

Harrow Closes Acquisition of TYRVAYA®

Indeterminate GlobeNewswire

6 hours ago

Rezolute Announces FDA Recommendation to Hold a Pre-BLA Meeting as a Precursor to Submitting a Biologics License Application (BLA) for Congenital Hyperinsulinism

Indeterminate GlobeNewswire

6 hours ago

VisionWave Outlines Development of Autonomous Defense Ecosystem Across Tactical UAV and Counter-UAS Applications

Indeterminate GlobeNewswire

6 hours ago

Patrick Tsang Brings Empulser to AIBotics in Definitive Defense-Technology Transaction

Indeterminate GlobeNewswire

6 hours ago

New Pico Laser for Tattoo Removal Includes Installation, On-Site Training and a Two-Year Warranty That Covers Technician Travel

Indeterminate GlobeNewswire

6 hours ago

Real-World Analysis Highlighting HAE Disease Experience and Gaps in Treatment Satisfaction Published in Advances in Therapy

Indeterminate GlobeNewswire

7 hours ago

Fortrea Announces Date for Third Quarter 2026 Financial Results and Conference Call

Indeterminate GlobeNewswire

7 hours ago

PartnerBridge Launches Strategic Fit to Bring Evidence‑Led, Decision-Making to SaaS Partnerships

Indeterminate GlobeNewswire

7 hours ago

Copper Mountain Technologies to Showcase BFx-02 Frequency Extension Base, Cross-Platform Software, and Integrated VNA Solutions at EuMW 2026

Indeterminate GlobeNewswire

7 hours ago

Vaxcyte Reports Positive Topline Data from OPUS-1, the Pivotal Adult Phase 3 Trial of VAX-31, the Company’s 31-Valent Pneumococcal Conjugate Vaccine Candidate

Indeterminate GlobeNewswire

9 hours ago

RosCept Capsules Introduces Ros Cept Multi-Ingredient Dietary Supplement for Brain Health, Memory and Concentration

Indeterminate GlobeNewswire

9 hours ago

FDA approves additional U.S. manufacturing capacity for SIMLANDI®, Alvotech’s biosimilar to Humira®

Indeterminate GlobeNewswire

9 hours ago

Aravax to Communicate Results of its Phase 2 Clinical Trial of PVX108, a Novel immunotherapy for the Treatment of Peanut Allergy, at Major Scientific Meetings in November 2026

Indeterminate GlobeNewswire

13 hours ago

Crypto News: AlphaPepe Presale Nears Binance Listing While XRP Price Prediction Targets $28

Indeterminate GlobeNewswire